Harmony Biosciences Holdings Inc (HRMY)

05:10 AM

Harmony Biosciences to Announce Q4 & Full Year 2024 Results on February 25, 2025 - MSN

05:10 AM

Feb 20, 2025

Harmony Biosciences (NASDAQ:HRMY) Receives Buy Rating from HC Wainwright - MarketBeat

Feb 20, 2025

Feb 20, 2025

Harmony Biosciences (NASDAQ:HRMY) Shares Gap Down After Analyst Downgrade - MarketBeat

Feb 20, 2025

Feb 20, 2025

‘Short-Tem Setback’ for Harmony Biosciences in Idiopathic Hypersomnia Application for Pitolisant - Sleep Review

Feb 20, 2025

Feb 20, 2025

Harmony Biosciences price target cut to $42 at Mizuho - Investing.com

Feb 20, 2025

Feb 20, 2025

Harmony Biosciences Faces Regulatory Setback, Outlines Future Plans for Pitolisant - MyChesCo

Feb 20, 2025

Feb 20, 2025

H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY) - StreetInsider.com

Feb 20, 2025

Feb 20, 2025

Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $42 at Mizuho - StreetInsider.com

Feb 20, 2025

Feb 19, 2025

Harmony Biosciences Stock Falls On FDA Setback For Pitolisant In Sleeping Disorder - AOL

Feb 19, 2025

Feb 19, 2025

Harmony Gets Dissonant FDA Response For Wakix In Idiopathic Hypersomnia - News & Insights

Feb 19, 2025

Feb 19, 2025

Needham & Company LLC Lowers Harmony Biosciences (NASDAQ:HRMY) Price Target to $50.00 - MarketBeat

Feb 19, 2025

Feb 19, 2025

Harmony Biosciences's sleep disorder treatment gets FDA Refuse to File letter - Seeking Alpha

Feb 19, 2025

Feb 19, 2025

FDA issues RTF to Harmony Biosciences for IH drug By Investing.com - Investing.com South Africa

Feb 19, 2025

Feb 19, 2025

FDA issues RTF to Harmony Biosciences for IH drug - Investing.com India

Feb 19, 2025

Feb 19, 2025

Harmony Biosciences Receives US FDA's Refusal to File Letter Related to Application for Pitolisant in Idiopathic Hypersomnia - Marketscreener.com

Feb 19, 2025

Feb 19, 2025

Harmony Biosciences Receives FDA Refusal To File Letter For Pitolisant In Idiopathic Hypersomnia - Nasdaq

Feb 19, 2025

Feb 19, 2025

Harmony Biosciences stock tumbles after FDA setback By Investing.com - Investing.com Australia

Feb 19, 2025

Feb 19, 2025

Harmony Biosciences Provides Update on the Status of the Supplemental New Drug Application for Pitolisant in Idiopathic Hypersomnia - Business Wire

Feb 19, 2025

Feb 19, 2025

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Short Interest Down 31.8% in January - MarketBeat

Feb 19, 2025

Feb 18, 2025

VCYT: 3 Emerging Biotech Firms Pioneering Next-Gen Therapies - StockNews.com

Feb 18, 2025

Feb 18, 2025

Earnings Alert: Harmony Biosciences Sets Date for Critical Q4 & FY2024 Financial Report - StockTitan

Feb 18, 2025

Feb 18, 2025

HRMY or ONC: Which Is the Better Value Stock Right Now? - MSN

Feb 18, 2025

Feb 17, 2025

Long Term Trading Analysis for (HRMY) - Stock Traders Daily

Feb 17, 2025

Feb 17, 2025

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives $55.00 Average Target Price from Brokerages - MarketBeat

Feb 17, 2025

Feb 15, 2025

HRMY FY2024 EPS Estimate Raised by Cantor Fitzgerald - MarketBeat

Feb 15, 2025

Feb 15, 2025

Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Shares Not Telling The Full Story - Simply Wall St

Feb 15, 2025

Feb 14, 2025

Deutsche Bank Aktiengesellschaft Begins Coverage on Harmony Biosciences (NASDAQ:HRMY) - MarketBeat

Feb 14, 2025

Feb 14, 2025

Deutsche Bank sets Harmony Biosciences stock Buy rating, $55 target - MSN

Feb 14, 2025

Feb 14, 2025

Polaris Capital Management LLC Acquires 13,300 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat

Feb 14, 2025

Feb 13, 2025

Here is Why Growth Investors Should Buy Harmony Biosciences (HRMY) Now - MSN

Feb 13, 2025

Feb 12, 2025

Plymouth Meeting’s Harmony Biosciences Eyes $3B in Sales with New Treatments on the Way - MSN

Feb 12, 2025

Feb 12, 2025

Harmony Biosciences Holdings, Inc (HRMY): A Cheap Biotech Stock to Invest In Now - Insider Monkey

Feb 12, 2025

Feb 12, 2025

Deutsche Bank Initiates Coverage of Harmony Biosciences Holdings (HRMY) with Buy Recommendation - MSN

Feb 12, 2025

Feb 11, 2025

Demystifying Harmony Biosciences: Insights From 5 Analyst Reviews - Benzinga

Feb 11, 2025

Feb 11, 2025

Deutsche Bank sets Harmony Biosciences stock Buy rating, $55 target By Investing.com - Investing.com Nigeria

Feb 11, 2025

Feb 11, 2025

Deutsche Bank Starts Harmony Biosciences Holdings Inc. (HRMY) at Buy - StreetInsider.com

Feb 11, 2025

Feb 06, 2025

(HRMY) Proactive Strategies - Stock Traders Daily

Feb 06, 2025

Feb 06, 2025

Is Harmony Biosciences Holdings Inc. (HRMY) a Biotech Stock to Consider? - Inkl

Feb 06, 2025

Feb 05, 2025

BlackRock, Inc.'s Strategic Acquisition in Harmony Biosciences H - GuruFocus.com

Feb 05, 2025

Feb 05, 2025

Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now? - Yahoo Finance

Feb 05, 2025

Feb 03, 2025

Top 5 US Stocks To Buy In February 2025 - Investing.com

Feb 03, 2025

Feb 03, 2025

SG Americas Securities LLC Grows Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat

Feb 03, 2025

Feb 02, 2025

HRMY vs. RGEN: Which Stock Is the Better Value Option? - MSN

Feb 02, 2025

Jan 31, 2025

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) CFO Sandip Kapadia Sells 1,775 Shares - MarketBeat

Jan 31, 2025

Jan 31, 2025

Insider Selling: Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Insider Sells 1,629 Shares of Stock - MarketBeat

Jan 31, 2025